Modeling tumor growth kinetics after treatment with pazopanib or placebo in patients with renal cell carcinoma. [electronic resource]
Producer: 20130827Description: 231-40 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Carcinoma, Renal Cell -- drug therapy
- Combined Modality Therapy
- Double-Blind Method
- Female
- Humans
- Indazoles
- Kidney -- drug effects
- Kidney Neoplasms -- drug therapy
- Kinetics
- Logistic Models
- Male
- Middle Aged
- Models, Biological
- Pharmacogenetics -- methods
- Pyrimidines -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Sulfonamides -- therapeutic use
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.